Institut universitaire de microbiologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


2321 publications

 
Correction to: Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
Andenmatten S., Opota O., Mazza-Stalder J., Nicod L., Greub G., Jaton K. European journal of clinical microbiology & infectious diseases. Peer-reviewed.
 
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections
Barbieri Francesca, Carlen Vincent, Martina Maria Grazia, Sannio Filomena, Cancade Sacha, Perini Cecilia, Restori Margherita, Crespan Emmanuele, Maga Giovanni, Docquier Jean-Denis et al. RSC Medicinal Chemistry.
 
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M., Giacobbe D.R., Agvald-Ohman C., Akova M., Alastruey-Izquierdo A., Arikan-Akdagli S., Azoulay E., Blot S., Cornely O.A., Cuenca-Estrella M. et al. Intensive care medicine. Peer-reviewed.
 
Tularemia on the rise in Switzerland? A one health approach is needed!
Buettcher M., Egli A., Albini S., Altpeter E., Labutin A., Guidi V., Tonolla M., Lienhard R., Opota O., Schmid P. et al. Infection. Peer-reviewed.
 
Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.
Filippidis P., Hovius L., Tissot F., Orasch C., Flückiger U., Siegemund M., Pagani J.L., Eggimann P., Marchetti O., Lamoth F. et al. Journal of critical care. Peer-reviewed.
 
Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation; a retrospective cohort study.
Fourre N., Zimmermann V., Senn L., Aruanno M., Guery B., Papadimitriou-Olivgeris M. Clinical infectious diseases. Peer-reviewed.
 
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.
Hoenigl M., Arastehfar A., Arendrup M.C., Brüggemann R., Carvalho A., Chiller T., Chen S., Egger M., Feys S., Gangneux J-P et al. Clinical microbiology reviews. Peer-reviewed.
 
Development and evaluation of an artificial intelligence for bacterial growth monitoring in clinical bacteriology.
Jacot D., Gizha S., Orny C., Fernandes M., Tricoli C., Marcelpoil R., Prod'hom G., Volle J-M, Greub G., Croxatto A. Journal of clinical microbiology. Peer-reviewed.
 
A potential role for chlamydial infection in rheumatoid arthritis development.
Lamacchia C., Aymon R., Hattel B.C., Aeby S., Kebbi-Beghdadi C C., Gilbert B., Studer O., Norris J.M., Nolers M.V., Demoruelle M.K. et al. Rheumatology. Peer-reviewed.
 
PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?
Lamoth F., Kontoyiannis D.P. Expert review of molecular diagnostics. Peer-reviewed.
 
Role of source control in critically ill candidemic patients: a multicenter retrospective study.
Marangos M., Ioannou P., Senn L., Spiliopoulou A., Tzalis S., Kolonitsiou F., Valta M., Kokkini S., Pagani J.L., Stafylaki D. et al. Infection. Peer-reviewed.
 
How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort.
Wegner F., Cabrera-Gil B., Tanguy A., Beckmann C., Beerenwinkel N., Bertelli C., Carrara M., Cerutti L., Chen C., Cordey S. et al. Microbiology spectrum. Peer-reviewed.
 
Benzene with Alkyl Chains Is a Universal Scaffold for Multivalent Virucidal Antivirals
Zhu Yong, Gasbarri Matteo, Zebret Soumaila, Pawar Sujeet, Mathez Gregory, Diderich Jacob, Valencia-Camargo Alma Delia, Russenberger Doris, Wang Heyun, Silva Paulo Henrique Jacob et al. ACS Central Science.
 
Inter-phylum circulation of a beta-lactamase-encoding gene: a rare but observable event.
Gschwind R., Petitjean M., Fournier C., Lao J., Clermont O., Nordmann P., Mellmann A., Denamur E., Poirel L., Ruppé E., 2024/04/03. Antimicrobial agents and chemotherapy, 68 (4) pp. e0145923. Peer-reviewed.
Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit.
Stavropoulou E., Huguenin A., Caruana G., Opota O., Perrottet N., Blanc D.S., Grandbastien B., Senn L., Bochud P.Y., Lamoth F., 2024/03/26. Swiss medical weekly, 154 p. 3730. Peer-reviewed.
Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform.
Sturm A., Jóźwiak G., Verge M.P., Munch L., Cathomen G., Vocat A., Luraschi-Eggemann A., Orlando C., Fromm K., Delarze E. et al., 2024/03/18. Nature communications, 15 (1) p. 2037. Peer-reviewed.
 
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
Kusejko K., Neofytos D., van Delden C., Hirsch H.H., Meylan P., Boggian K., Hirzel C., Garzoni C., Sidler D., Schnyder A. et al., 2024/03. Open forum infectious diseases, 11 (3) pp. ofae055. Peer-reviewed.
 
Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.
Kotliar D., Raju S., Tabrizi S., Odia I., Goba A., Momoh M., Sandi J.D., Nair P., Phelan E., Tariyal R. et al., 2024/03. Nature microbiology, 9 (3) pp. 751-762. Peer-reviewed.
 
Lung and sinus fungal infection imaging in immunocompromised patients.
Lamoth F., Prakash K., Beigelman-Aubry C., Baddley J.W., 2024/03. Clinical microbiology and infection, 30 (3) pp. 296-305. Peer-reviewed.
Aberrant Bodies: An Alternative Metabolic Homeostasis Allowing Survivability?
Kozusnik T., Adams S.E., Greub G., 2024/02/29. Microorganisms, 12 (3). Peer-reviewed.
The Chlamydia-related Waddlia chondrophila encodes functional type II toxin-antitoxin systems.
Ardissone S., Greub G., 2024/02/21. Applied and environmental microbiology, 90 (2) pp. e0068123. Peer-reviewed.
 
Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case-control study.
Alberto C., Lambeng N., Deffert C., Breville G., Gayet-Ageron A., Lalive P., Calmy A., Coste A., Papadimitriou-Olivgeris M., Braun D. et al., 2024/02/19. Sexually transmitted infections, 100 (2) pp. 63-69. Peer-reviewed.
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
 
Upc2-mediated mechanisms of azole resistance in Candida auris.
Li J., Aubry L., Brandalise D., Coste A.T., Sanglard D., Lamoth F., 2024/02/06. Microbiology spectrum, 12 (2) pp. e0352623. Peer-reviewed.
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Meyer Sauteur P.M., Beeton M.L., European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group, 2024/02. The Lancet. Microbe, 5 (2) pp. e100-e101. Peer-reviewed.
 
Proposed Framework for Conducting Clinically Relevant Translational Biomarker Research for the Diagnosis, Prognosis and Management of Sepsis.
Ventura F., Greub G., Liles W.C., Jacob S.T., 2024/01/30. Diagnostics, 14 (3). Peer-reviewed.
 
Antigenic Architecture of the H7N2 Influenza Virus Hemagglutinin Belonging to the North American Lineage.
Lyashko A.V., Timofeeva T.A., Rudneva I.A., Lomakina N.F., Treshchalina A.A., Gambaryan A.S., Sorokin E.V., Tsareva T.R., Adams S.E., Prilipov A.G. et al., 2023/12/22. International journal of molecular sciences, 25 (1) p. 212. Peer-reviewed.
 
From microbiome composition to functional engineering, one step at a time.
Burz S.D., Causevic S., Dal Co A., Dmitrijeva M., Engel P., Garrido-Sanz D., Greub G., Hapfelmeier S., Hardt W-D, Hatzimanikatis V. et al., 2023/12/20. Microbiology and molecular biology reviews, 87 (4) pp. e0006323. Peer-reviewed.
 
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
Huttner A., Agnandji S.T., Engler O., Hooper J.W., Kwilas S., Ricks K., Clements T.L., Jonsdottir H.R., Nakka S.S., Rothenberger S. et al., 2023/12. Clinical microbiology and infection, 29 (12) pp. 1587-1594. Peer-reviewed.
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting.
Filippidis P., Senn L., Poncet F., Grandbastien B., Prod'hom G., Greub G., Guery B., Blanc D.S., 2023/12. European journal of clinical microbiology & infectious diseases, 42 (12) pp. 1469-1476. Peer-reviewed.
 
In vivo reprogramming leads to premature death linked to hepatic and intestinal failure.
Parras A., Vílchez-Acosta A., Desdín-Micó G., Picó S., Mrabti C., Montenegro-Borbolla E., Maroun C.Y., Haghani A., Brooke R., Del Carmen Maza M. et al., 2023/12. Nature aging, 3 (12) pp. 1509-1520. Peer-reviewed.
 
Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin.
Findlay J., Sierra R., Raro OHF, Aires-de-Sousa M., Andrey D.O., Nordmann P., 2023/12. Journal of global antimicrobial resistance, 35 pp. 137-142. Peer-reviewed.
 
Publisher Correction: Fungal antigenic variation using mosaicism and reassortment of subtelomeric genes' repertoires.
Meier C.S., Pagni M., Richard S., Mühlethaler K., Almeida JMGCF, Nevez G., Cushion M.T., Calderón E.J., Hauser P.M., 2023/12/01. Nature communications, 14 (1) p. 7928. Peer-reviewed.
 
Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii.
Raro OHF, Bouvier M., Kerbol A., Decousser J.W., Poirel L., Nordmann P., 2023/12. European journal of clinical microbiology & infectious diseases, 42 (12) pp. 1511-1518. Peer-reviewed.
 
Effect of Zinc Oxide and Copper Sulfate on Antibiotic Resistance Plasmid Transfer in Escherichia coli.
Raro OHF, Poirel L., Nordmann P., 2023/11/29. Microorganisms, 11 (12) p. 2880. Peer-reviewed.
Sex and Age Impact CD4+ T Cell Susceptibility to HIV In Vitro through Cell Activation Dynamics.
Brandt L., Angelino P., Martinez R., Cristinelli S., Ciuffi A., 2023/11/23. Cells, 12 (23) p. 2689. Peer-reviewed.
 
Presence and Persistence of Andes Virus RNA in Human Semen.
Züst R., Ackermann-Gäumann R., Liechti N., Siegrist D., Ryter S., Portmann J., Lenz N., Beuret C., Koller R., Staehelin C. et al., 2023/11/17. Viruses, 15 (11) p. 2266. Peer-reviewed.
Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland.
Schürch S., Gindro K., Schnee S., Dubuis P.H., Codina J.M., Wilhelm M., Riat A., Lamoth F., Sanglard D., 2023/11/06. Medical mycology, 61 (11) pp. myad110. Peer-reviewed.
 
Rapid detection of temocillin resistance in Enterobacterales.
Findlay J., Poirel L., Nordmann P., 2023/11/06. The Journal of antimicrobial chemotherapy, 78 (11) pp. 2770-2771. Peer-reviewed.
 
Fungal antigenic variation using mosaicism and reassortment of subtelomeric genes' repertoires.
Meier C.S., Pagni M., Richard S., Mühlethaler K., Almeida JMGCF, Nevez G., Cushion M.T., Calderón E.J., Hauser P.M., 2023/11/02. Nature communications, 14 (1) p. 7026. Peer-reviewed.
Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe.
Mitjà O., Padovese V., Folch C., Rossoni I., Marks M., Rodríguez I Arias M.A., Telenti A., Ciuffi A., Blondeel K., Mårdh O. et al., 2023/11. The Lancet regional health. Europe, 34 p. 100742. Peer-reviewed.
Luminescent reporter cells enable the identification of broad-spectrum antivirals against emerging viruses.
Löw K., Möller R., Stegmann C., Becker M., Rehburg L., Obernolte H., Schaudien D., Oestereich L., Braun A., Kunz S. et al., 2023/11. Journal of medical virology, 95 (11) pp. e29211. Peer-reviewed.
 
Rapid detection of imipenem/relebactam susceptibility/resistance in Enterobacterales
Bouvier Maxime, Raro Otávio Hallal Ferreira, Kerbol Auriane, Poirel Laurent, Nordmann Patrice, 2023/11. Clinical Microbiology and Infection, 29 (11) pp. 1453.e1-1453.e5. Peer-reviewed.
Resist Acineto rapid immunological test for the detection of acquired carbapenemase producers among Acinetobacter spp.
Bouvier M., Kerbol A., Findlay J., Freire S., Poirel L., Nordmann P., 2023/11. Diagnostic microbiology and infectious disease, 107 (3) p. 116043. Peer-reviewed.
 
Securing the future of clinical microbiology and infectious diseases through mentorship
Neidhöfer Claudio, Kherabi Yousra, Van Asten Suzanne, Bulescu Casandra, Kraef Christian, Power Nicholas, Caruana Giorgia, Velikov Petar, 2023/11. Clinical Microbiology and Infection, 29 (11) pp. 1358-1360. Peer-reviewed.
 
Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in Enterobacterales.
Viguier C., Bouvier M., Sadek M., Kerbol A., Poirel L., Nordmann P., 2023/10/24. Journal of clinical microbiology, 61 (10) pp. e0058823. Peer-reviewed.
 
Non-Steroidal Estrogens Inhibit Influenza Virus by Interacting with Hemagglutinin and Preventing Viral Fusion.
Franzi E., Mathez G., Dinant S., Deloizy C., Kaiser L., Tapparel C., Le Goffic R., Cagno V., 2023/10/19. International journal of molecular sciences, 24 (20). Peer-reviewed.
An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates.
Aubry R., Buyck J., Prouvensier L., Decousser J-W, Nordmann P., Wicha S.G., Marchand S., Grégoire N., 2023/10/18. Antimicrobial agents and chemotherapy, 67 (10) pp. e0030123. Peer-reviewed.
 
Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Escherichia coli.
Le Terrier C., Nordmann P., Bouvier M., Poirel L., 2023/10/18. Antimicrobial agents and chemotherapy, 67 (10) pp. e0054723. Peer-reviewed.
 
Rapid meropenem/vaborbactam NP test for detecting susceptibility/resistance in Enterobacterales.
Nordmann P., Kerbol A., Bouvier M., Sadek M., Poirel L., Raro OHF, 2023/10/03. The Journal of antimicrobial chemotherapy, 78 (10) pp. 2428-2434. Peer-reviewed.
Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO).
Fischer F.B., Bigler M., Mäusezahl D., Hattendorf J., Egli A., Julian T.R., Rölli F., Gaia V., Wymann M., Fridez F. et al., 2023/10. Infection, 51 (5) pp. 1467-1479. Peer-reviewed.
 
Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosis.
Vocat A., Sturm A., Jóźwiak G., Cathomen G., Świątkowski M., Buga R., Wielgoszewski G., Cichocka D., Greub G., Opota O., 2023/10. Microbes and infection, 25 (7) p. 105151. Peer-reviewed.
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians.
Casutt A., Lamoth F., Lortholary O., Prior J.O., Tonglet A., Manuel O., Bergeron A., Beigelman-Aubry C., 2023/09/30. European respiratory review, 32 (169). Peer-reviewed.
 
Ticks and Chlamydia-Related Bacteria in Swiss Zoological Gardens Compared to in Contiguous and Distant Control Areas.
Vanat V., Aeby S., Greub G., 2023/09/30. Microorganisms, 11 (10) p. 2468. Peer-reviewed.
 
Spontaneous Aberrant Bodies Formation in Human Pneumocytes Infected with Estrella lausannensis.
Rovero A., Kebbi-Beghdadi C., Greub G., 2023/09/22. Microorganisms, 11 (10) p. 2368. Peer-reviewed.
Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood.
Jonsdottir H.R., Zysset D., Lenz N., Siegrist D., Ruedin Y., Ryter S., Züst R., Geissmann Y., Ackermann-Gäumann R., Engler O.B. et al., 2023/09/21. Scientific reports, 13 (1) p. 15718. Peer-reviewed.
 
IVDR: Analysis of the Social, Economic, and Practical Consequences of the Application of an Ordinance of the In Vitro Diagnostic Ordinance in Switzerland.
Coste A.T., Egli A., Schrenzel J., Nickel B., Zbinden A., Lienhard R., Dumoulin A., Risch M., Greub G., Coordinated Clinical Commission of Microbiology (CCCM), 2023/09/11. Diagnostics, 13 (18). Peer-reviewed.
Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer.
Hallal Ferreira Raro O., Poirel L., Tocco M., Nordmann P., 2023/09/05. The Journal of antimicrobial chemotherapy, 78 (9) pp. 2209-2216. Peer-reviewed.
Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern.
Le Terrier C., Nordmann P., Buchs C., Di DYW, Rossolini G.M., Stephan R., Castanheira M., Poirel L., 2023/09/05. The Journal of antimicrobial chemotherapy, 78 (9) pp. 2382-2384. Peer-reviewed.
 
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren P.J., Porreca I., Iaconis G., Mok H.P., Mukhopadhyay S., Karakoc E., Cristinelli S., Pomilla C., Bartha I., Thorball C.W. et al., 2023/09. Nature, 621 (7979) pp. E42. Peer-reviewed.
 
Use of gene sequences as type for naming prokaryotes: Recommendations of the international committee on the taxonomy of chlamydiae.
Greub G., Pillonel T., Bavoil P.M., Borel N., Campbell L.A., Dean D., Hefty S., Horn M., Morré S.A., Ouellette S.P. et al., 2023/09. New microbes and new infections, 54 p. 101158. Peer-reviewed.
Small Molecules Targeting Viral RNA.
Mathez G., Cagno V., 2023/08/31. International journal of molecular sciences, 24 (17) p. 13500. Peer-reviewed.
 
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T., Choi Y., Pagani J.L., Kritikos A., Papadimitriou-Olivgeris M., Méan M., Scherz V., Opota O., Greub G., Guery B. et al., 2023/08/18. BMC infectious diseases, 23 (1) p. 537. Peer-reviewed.
 
International Committee on Systematics of Prokaryotes Subcommittee on the taxonomy of Chlamydiae: Minutes of the closed meeting, March 20, Meeting of the Chlamydia Research Society, Omaha, NE, USA
Borel Nicole, Greub Gilbert, 2023/08/16. International Journal of Systematic and Evolutionary Microbiology, 73 (8). Peer-reviewed.
 
Oedème palpébral 24 heures après le premier vaccin contre le COVID-19
Dao Mai-Chi Diane, Opota Onya, Blum Sabine, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren P.J., Porreca I., Iaconis G., Mok H.P., Mukhopadhyay S., Karakoc E., Cristinelli S., Pomilla C., Bartha I., Thorball C.W. et al., 2023/08. Nature, 620 (7976) pp. 1025-1030. Peer-reviewed.
 
Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?
Albrich W.C., Lamoth F., 2023/08/01. American journal of respiratory and critical care medicine, 208 (3) pp. 230-231. Peer-reviewed.
 
Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa.
Le Terrier C., Nordmann P., Freret C., Seigneur M., Poirel L., 2023/07/18. Antimicrobial agents and chemotherapy, 67 (7) pp. e0033923. Peer-reviewed.
 
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F., Nucci M., Fernandez-Cruz A., Azoulay E., Lanternier F., Bremerich J., Einsele H., Johnson E., Lehrnbecher T., Mercier T. et al., 2023/07/06. Medical mycology, 61 (7). Peer-reviewed.
The Statistical Analysis of the Varying Brain.
Chén Oliver Y., Thanh Vũ Duy, Greub Gilbert, Cao Hengyi, He Xingru, Muller Yannick, Petrovas Constantinos, Shou Haochang, Nguyen Viet-Dung, Zhi Bangdong et al., 2023/07/02. dans IEEE Statistical Signal Processing (SSP). Peer-reviewed.
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Haefliger D., Marzolini C., Lamoth F., Pabst T., Buclin T., Livio F., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 2304-2308. Peer-reviewed.
Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection.
Bermúdez-Méndez E., Angelino P., van Keulen L., van de Water S., Rockx B., Pijlman G.P., Ciuffi A., Kortekaas J., Wichgers Schreur P.J., 2023/06/29. Journal of virology, 97 (6) pp. e0041523. Peer-reviewed.
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study.
Avery E.F., Kleynhans J.N., Ledergerber B., Schoepf I.C., Thorball C.W., Kootstra N.A., Reiss P., Ryom L., Braun D.L., Thurnheer M.C. et al., 2023/06/08. Clinical infectious diseases, 76 (11) pp. 1969-1979. Peer-reviewed.
 
Novel Approaches in the Management of Mucormycosis
Lamoth Frederic, 2023/06. Current Fungal Infection Reports, 17 (2) pp. 98-107.
 
Temperature Affects the Host Range of Rhabdochlamydia porcellionis.
Marquis B., Ardissone S., Greub G., 2023/05/31. Applied and environmental microbiology, 89 (5) pp. e0030923. Peer-reviewed.
 
Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales.
Sadek M., Bosch Duran J., Poirel L., Nordmann P., 2023/05/17. Antimicrobial agents and chemotherapy, 67 (5) pp. e0007823. Peer-reviewed.
 
Leptospirose, le défi diagnostique d’un cas autochtone [Leptospirosis, the diagnostic challenge of an indigenous case]
Martelli F., Gay Des Combes Gliven P., De Vallière S., Favrat B., Greub G., Kokkinakis I., 2023/05/10. Revue medicale suisse, 19 (826) pp. 916-919. Peer-reviewed.
Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
de La Harpe R., Thorball C.W., Redin C., Fournier S., Müller O., Strambo D., Michel P., Vollenweider P., Marques-Vidal P., Fellay J. et al., 2023/05/09. European journal of preventive cardiology, 30 (7) pp. 561-571. Peer-reviewed.
 
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates.
Le Terrier C., Nordmann P., Sadek M., Poirel L., 2023/05/03. The Journal of antimicrobial chemotherapy, 78 (5) pp. 1191-1194. Peer-reviewed.
 
Changes in the fungal nomenclature: Why and how to manage?
Hennequin C., Coste A., Imbert C., 2023/05. Journal de mycologie medicale, 33 (2) p. 101404. Peer-reviewed.
 
Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
Li J., Coste A.T., Liechti M., Bachmann D., Sanglard D., Lamoth F., 2023/05/01. Antimicrobial agents and chemotherapy, 65 (5) pp. e02663-20. Peer-reviewed.
Resistance to ceftazidime-avibactam in a KPC-2-producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25.
Findlay J., Poirel L., Bouvier M., Gaia V., Nordmann P., 2023/05. European journal of clinical microbiology & infectious diseases, 42 (5) pp. 639-644. Peer-reviewed.
The Swiss Pathogen Surveillance Platform - towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata.
Neves A., Walther D., Martin-Campos T., Barbie V., Bertelli C., Blanc D., Bouchet G., Erard F., Greub G., Hirsch H.H. et al., 2023/05. Microbial genomics, 9 (5). Peer-reviewed.
 
Échinococcose alvéolaire : prise en charge en 2023 [2023 update on alveolar echinococcosis]
Gauthiez E., Uldry E., Coste A.T., Prior J., Cavassini M., Munting A., 2023/04/12. Revue medicale suisse, 19 (822) pp. 708-712. Peer-reviewed.
 
NDM-9 resistance to taniborbactam.
Le Terrier C., Gruenig V., Fournier C., Nordmann P., Poirel L., 2023/04. The Lancet. Infectious diseases, 23 (4) pp. 401-402. Peer-reviewed.
 
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections.
Sanya DRA, Onésime D., Vizzarro G., Jacquier N., 2023/03/30. BMC microbiology, 23 (1) p. 86. Peer-reviewed.
 
Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland.
Hallal Ferreira Raro O., Nordmann P., Dominguez Pino M., Findlay J., Poirel L., 2023/03/16. Antimicrobial agents and chemotherapy, 67 (3) pp. e0142422. Peer-reviewed.
 
Rectal shedding of monkeypox virus in a patient coinfected with Chlamydia trachomatis and Neisseria gonorrhoeae: a case report.
Desgranges F., Glampedakis E., Christinet V., Encarnação S., Fernandes C., Greub G., Opota O., Cavassini M., 2023/03/06. Journal of medical case reports, 17 (1) p. 94. Peer-reviewed.
Emergence of OXA-484, an OXA-48-type beta-lactamase, in Switzerland.
Findlay J., Duran J.B., Poirel L., Nordmann P., 2023/03. Journal of global antimicrobial resistance, 32 pp. 131-133. Peer-reviewed.
In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates.
Findlay J., Poirel L., Nordmann P., 2023/03. Journal of global antimicrobial resistance, 32 pp. 66-71. Peer-reviewed.
 
SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works.
Cassari L., Pavan A., Zoia G., Chinellato M., Zeni E., Grinzato A., Rothenberger S., Cendron L., Dettin M., Pasquato A., 2023/03/01. International journal of molecular sciences, 24 (5) p. 4791. Peer-reviewed.
 
What Is New in Pulmonary Mucormycosis?
Danion F., Coste A., Le Hyaric C., Melenotte C., Lamoth F., Calandra T., Garcia-Hermoso D., Aimanianda V., Lanternier F., Lortholary O., 2023/02/28. Journal of fungi, 9 (3) p. 307. Peer-reviewed.
 
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A., Caruana G., Poissy J., Mamin A., Bachmann D., Pagani J.L., Coste A.T., Lamoth F., 2023/02/22. Journal of clinical microbiology, 61 (2) pp. e0169122. Peer-reviewed.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Maertens J., Lodewyck T., Donnelly J.P., Chantepie S., Robin C., Blijlevens N., Turlure P., Selleslag D., Baron F., Aoun M. et al., 2023/02/18. Clinical infectious diseases, 76 (4) pp. 674-682. Peer-reviewed.
 
Overruling of Procalcitonin-Guided Antibiotics for Lower Respiratory Tract Infections in Primary Care: Ancillary Study of a Randomized Controlled Trial.
Knüsli J., Lhopitallier L., Kronenberg A., Meuwly J.Y., Opota O., Perrenoud M.A., Page M.A., Kain K.C., Mamin A., D'Acremont V. et al., 2023/02/12. Antibiotics, 12 (2) p. 377. Peer-reviewed.
An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis.
Reuter J., Otten C., Jacquier N., Lee J., Mengin-Lecreulx D., Löckener I., Kluj R., Mayer C., Corona F., Dannenberg J. et al., 2023/02. PLoS pathogens, 19 (2) pp. e1011047. Peer-reviewed.
 
Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains.
Cuénod A., Aerni M., Bagutti C., Bayraktar B., Boz E.S., Carneiro C.B., Casanova C., Coste A.T., Damborg P., van Dam D.W. et al., 2023/02. Clinical microbiology and infection, 29 (2) pp. 190-199. Peer-reviewed.
 
International Committee on Systematics of Prokaryotes (ICSP) Subcommittee on the taxonomy of Chlamydiae: Minutes of the closed meeting, 25 August 2022, ESCCAR Meeting Lausanne, Switzerland
Borel Nicole, Greub Gilbert, 2023/01/27. dans International Journal of Systematic and Evolutionary Microbiology, Microbiology Society.
 
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.
Nadeau S.A., Vaughan T.G., Beckmann C., Topolsky I., Chen C., Hodcroft E., Schär T., Nissen I., Santacroce N., Burcklen E. et al., 2023/01/25. Science translational medicine, 15 (680) pp. eabn7979. Peer-reviewed.
 
Estimation de l’incidence de covid long en 2020 ou 2021 (Periode pre-omicron).
Meylan P., 2023/01/18. Revue medicale suisse, 19 (809-10) pp. 90-91. Peer-reviewed.
A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia.
Asare P.T., Lee C.H., Hürlimann V., Teo Y., Cuénod A., Akduman N., Gekeler C., Afrizal A., Corthesy M., Kohout C. et al., 2023. Frontiers in microbiology, 14 p. 1104707. Peer-reviewed.
Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: A prospective comparative clinical trial.
Schwob J.M., Miauton A., Petrovic D., Perdrix J., Senn N., Gouveia A., Jaton K., Opota O., Maillard A., Minghelli G. et al., 2023. PloS one, 18 (2) pp. e0282150. Peer-reviewed.
Associations of genetic and infectious risk factors with coronary heart disease.
Hodel F., Xu Z.M., Thorball C.W., de La Harpe R., Letang-Mathieu P., Brenner N., Butt J., Bender N., Waterboer T., Marques-Vidal P.M. et al., 2023. eLife, 12 pp. e79742. Peer-reviewed.
 
Beyond Traditional Culture: New Approaches for a Rapid Detection and Identification of Microorganisms and their Antimicrobial Resistance
Jordana-Lluch Elena, Mancini Nicasio, W. A. Rossen John, Opota Onya, 2023., Frontier Media SA.
 
Corrigendum: A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia.
Asare P.T., Lee C.H., Hürlimann V., Teo Y., Cuénod A., Akduman N., Gekeler C., Afrizal A., Corthesy M., Kohout C. et al., 2023. Frontiers in microbiology, 14 p. 1208177. Peer-reviewed.
Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician.
Lamoth F., 2023. Infection and drug resistance, 16 pp. 1087-1097. Peer-reviewed.
Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.
Boldi M.O., Denis-Lessard J., Neziri R., Brouillet R., von-Garnier C., Chavez V., Mazza-Stalder J., Jaton K., Greub G., Opota O., 2023. Frontiers in cellular and infection microbiology, 13 p. 1131241. Peer-reviewed.
Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa.
Sadek M., Le Guern R., Kipnis E., Gosset P., Poirel L., Dessein R., Nordmann P., 2023/01. European journal of clinical microbiology & infectious diseases, 42 (1) pp. 61-66. Peer-reviewed.
 
Proprotein convertases regulate trafficking and maturation of key proteins within the secretory pathway
Cendron Laura, Rothenberger Sylvia, Cassari Leonardo, Dettin Monica, Pasquato Antonella, 2023. pp. 1-54 dans Secretory Proteins, Elsevier.
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection.
Jacot D., von Rotz U., Pellaton C., Blondet F., Aebischer O., Perreau M., De Rham M., Pantaleo G., Marchetti O., Greub G., 2023. Microbes and infection, 25 (1-2) p. 105077. Peer-reviewed.
 
Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.
Gachoud D., Bertelli C., Rufer N., 2023/01. British journal of haematology, 200 (2) pp. e25-e27. Peer-reviewed.
 
Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice
Schrevens Sanne, Torelli Riccardo, Sanguinetti Maurizio, Sanglard Dominque, 2023. pp. 239-247 dans Antifungal Drug Resistance, Springer US.
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F., Calandra T., 2022/12/31. European respiratory review, 31 (166) p. 220114. Peer-reviewed.
Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital.
Munting A., Damas J., Viala B., Prod'hom G., Guery B., Senn L., 2022/12/30. Antimicrobial resistance and infection control, 11 (1) p. 165. Peer-reviewed.
 
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases.
Le Terrier C., Nordmann P., Poirel L., 2022/12/23. The Journal of antimicrobial chemotherapy, 78 (1) pp. 101-107. Peer-reviewed.
Anidulafungin Treatment Blocks the Sexual Cycle of Pneumocystis murina and Prevents Growth and Survival without Rescue by an Alternative Mode of Replication.
Cushion M.T., Ashbaugh A., Sayson S.G., Mosley C., Hauser P.M., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0290622. Peer-reviewed.
 
Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON).
Kritikos A., Caruana G., Lazor-Blanchet C., Currat M., Chiche J.D., Vollenweider P., Bart P.A., Opota O., Greub G., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0392322. Peer-reviewed.
 
Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak.
Cameron D.R., Pitton M., Oberhaensli S., Schlegel K., Prod'hom G., Blanc D.S., Jakob S.M., Que Y.A., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0274322. Peer-reviewed.
Alpha and Omicron SARS-CoV-2 Adaptation in an Upper Respiratory Tract Model.
Mathez G., Pillonel T., Bertelli C., Cagno V., 2022/12/20. Viruses, 15 (1) p. 13. Peer-reviewed.
Evaluation of novel immunological rapid test (K.N.I.V.O. Detection K-Set) for rapid detection of carbapenemase producers in multidrug-resistant gram negatives.
Sadek M., Bouvier M., Kerbol A., Poirel L., Nordmann P., 2022/12. Diagnostic microbiology and infectious disease, 104 (4) p. 115761. Peer-reviewed.
Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting.
Varricchio C., Mathez G., Pillonel T., Bertelli C., Kaiser L., Tapparel C., Brancale A., Cagno V., 2022/12. Antiviral research, 208 p. 105452. Peer-reviewed.
 
In vitro synergistic action of TAT-RasGAP<sub>317-326</sub> peptide with antibiotics against Gram-negative pathogens.
Vizzarro G., Jacquier N., 2022/12. Journal of global antimicrobial resistance, 31 pp. 295-303. Peer-reviewed.
 
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.
Bergeron A., Mikulska M., De Greef J., Bondeelle L., Franquet T., Herrmann J.L., Lange C., Spriet I., Akova M., Donnelly J.P. et al., 2022/12. The Lancet. Infectious diseases, 22 (12) pp. e359-e369. Peer-reviewed.
 
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis.
Giacobbe D.R., Asperges E., Cortegiani A., Grecchi C., Rebuffi C., Zuccaro V., Scudeller L., Bassetti M., FUNDICU investigators, 2022/12. Mycoses, 65 (12) pp. 1073-1111. Peer-reviewed.
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
Rothenberger S., Hurdiss D.L., Walser M., Malvezzi F., Mayor J., Ryter S., Moreno H., Liechti N., Bosshart A., Iss C. et al., 2022/12. Nature biotechnology, 40 (12) pp. 1845-1854. Peer-reviewed.
The «Amish» NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation.
Redin C., Pavlidou D.C., Bhuiyan Z., Porretta A.P., Monney P., Bedoni N., Maurer F., Sekarski N., Atallah I., Émeline D. et al., 2022/12. European journal of medical genetics, 65 (12) p. 104627. Peer-reviewed.
Using in vivo transcriptomics and RNA enrichment to identify genes involved in virulence of Candida glabrata.
Schrevens S., Durandau E., Tran VDT, Sanglard D., 2022/12. Virulence, 13 (1) pp. 1285-1303. Peer-reviewed.
 
Variability of Primary Sjögren's Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus.
Trutschel D., Bost P., Mariette X., Bondet V., Llibre A., Posseme C., Charbit B., Thorball C.W., Jonsson R., Lessard C.J. et al., 2022/12. Arthritis & rheumatology, 74 (12) pp. 1991-2002. Peer-reviewed.
 
Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales.
Nordmann P., Bouvier M., Poirel L., Sadek M., 2022/11/28. The Journal of antimicrobial chemotherapy, 77 (12) pp. 3456-3461. Peer-reviewed.
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms.
Bianco G., Gaibani P., Comini S., Boattini M., Banche G., Costa C., Cavallo R., Nordmann P., 2022/11/22. Antibiotics, 11 (12). Peer-reviewed.
Investigating nanomotion-based technology (Resistell AST) for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: protocol for a prospective, observational, cross-sectional, single-arm study.
Caruana G., Kritikos A., Vocat A., Luraschi A., Delarze E., Sturm A., Pla Verge M., Jozwiak G., Kushwaha S., Delaloye J. et al., 2022/11/21. BMJ open, 12 (11) pp. e064016. Peer-reviewed.
 
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Mercier T., Desfontaine V., Cruchon S., Da Silva Pereira Clara J.A., Briki M., Mazza-Stalder J., Kajkus A., Burger R., Suttels V., Buclin T. et al., 2022/11/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1211 p. 123456. Peer-reviewed.
 
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents.
Gachoud D., Pillonel T., Tsilimidos G., Battolla D., Dumas D., Opota O., Fontana S., Vollenweider P., Manuel O., Greub G. et al., 2022/11. British journal of haematology, 199 (4) pp. 549-559. Peer-reviewed.
Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.
Findlay J., Perreten V., Poirel L., Nordmann P., 2022/11. European journal of clinical microbiology & infectious diseases, 41 (11) pp. 1355-1360. Peer-reviewed.
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data.
Bassetti M., Zuccaro V., Asperges E., Scudeller L., Giacobbe D.R., FUNDICU investigators (collaborators), 2022/11. The Journal of infection, 85 (5) pp. 573-607. Peer-reviewed.
Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase.
Sadek M., Saad A.M., Nordmann P., Poirel L., 2022/10/26. Antibiotics, 11 (11). Peer-reviewed.
Lignin: A Sustainable Antiviral Coating Material.
Boarino A., Wang H., Olgiati F., Artusio F., Özkan M., Bertella S., Razza N., Cagno V., Luterbacher J.S., Klok H.A. et al., 2022/10/24. ACS sustainable chemistry & engineering, 10 (42) pp. 14001-14010. Peer-reviewed.
 
In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae.
Findlay J., Rens C., Poirel L., Nordmann P., 2022/10/18. Antimicrobial agents and chemotherapy, 66 (10) pp. e0091822. Peer-reviewed.
Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
Walser M., Mayor J., Rothenberger S., 2022/10/12. Viruses, 14 (10) p. 2242. Peer-reviewed.
An anti-influenza combined therapy assessed by single cell RNA-sequencing.
Medaglia C., Kolpakov I., Zwygart A.C., Zhu Y., Constant S., Huang S., Cagno V., Dermitzakis E.T., Stellacci F., Xenarios I. et al., 2022/10/10. Communications biology, 5 (1) p. 1075. Peer-reviewed.
Cross-reaction of naturally-produced β-lactamases from Citrobacter farmeri and Citrobacter amalonaticus with immunological detection of CTX-M enzymes.
Ortiz de la Rosa J.M., Bouvier M., Poirel L., Greub G., Blanc D., Nordmann P., 2022/10. Diagnostic microbiology and infectious disease, 104 (2) p. 115760. Peer-reviewed.
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Laager M., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2022/10. The Journal of hospital infection, 128 pp. 47-53. Peer-reviewed.
 
Author Correction: Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin.
Staub E., Marti H., Biondi R., Levi A., Donati M., Leonard C.A., Ley S.D., Pillonel T., Greub G., Seth-Smith HMB et al., 2022/09/28. Scientific reports, 12 (1) p. 16171. Peer-reviewed.
 
Prevalence and Factors Associated with Prosthetic Joint Infections in Patients with Staphylococcus aureus Bacteraemia: A 7-Year Retrospective Study.
Papadimitriou-Olivgeris M., Senn L., Bertelli C., Grandbastien B., Steinmetz S., Boillat-Blanco N., 2022/09/28. Antibiotics, 11 (10) p. 1323. Peer-reviewed.
A novel Candida glabrata doxycycline-inducible system for in vitro/in vivo use.
Schrevens S., Sanglard D., 2022/09/24. FEMS yeast research, 22 (1) pp. foac046. Peer-reviewed.
The importance of antimicrobial resistance in medical mycology.
Gow NAR, Johnson C., Berman J., Coste A.T., Cuomo C.A., Perlin D.S., Bicanic T., Harrison T.S., Wiederhold N., Bromley M. et al., 2022/09/12. Nature communications, 13 (1) p. 5352. Peer-reviewed.
In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
Findlay J., Poirel L., Bouvier M., Nordmann P., 2022/09. Journal of global antimicrobial resistance, 30 pp. 445-450. Peer-reviewed.
 
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.
Lamoth F., Lewis R.E., Kontoyiannis D.P., 2022/08/31. Clinical infectious diseases, 75 (3) pp. 534-544. Peer-reviewed.
Cell Fusion May Be Involved in the Homothallic Mating of Pneumocystis Species.
Hauser P.M., Almeida JMGCF, Richard S., Meier C.S., 2022/08/30. mBio, 13 (4) pp. e0085922. Peer-reviewed.
 
High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies.
Tschopp J., Brunel A.S., Spertini O., Croxatto A., Lamoth F., Bochud P.Y., 2022/08/25. Clinical infectious diseases, 75 (2) pp. 330-333. Peer-reviewed.
 
NDM-35-Producing ST167 Escherichia coli Highly Resistant to β-Lactams Including Cefiderocol.
Poirel L., Ortiz de la Rosa J.M., Sakaoglu Z., Kusaksizoglu A., Sadek M., Nordmann P., 2022/08/16. Antimicrobial agents and chemotherapy, 66 (8) pp. e0031122. Peer-reviewed.
An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
Hervouet K., Ferrié M., Ankavay M., Montpellier C., Camuzet C., Alexandre V., Dembélé A., Lecoeur C., Foe A.T., Bouquet P. et al., 2022/08. PLoS pathogens, 18 (8) pp. e1010798. Peer-reviewed.
 
Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.
Kampouri E., Filippidis P., Wölfle M., Taveira A., Badinski T., Croxatto A., Galperine T., Grandbastien B., Achermann Y., Guery B., 2022/08. Infectious diseases now, 52 (5) pp. 267-272. Peer-reviewed.
Host genomics of SARS-CoV-2 infection.
Redin C., Thorball C.W., Fellay J., 2022/08. European journal of human genetics, 30 (8) pp. 908-914. Peer-reviewed.
Modelling the Extremes of Seasonal Viruses and Hospital Congestion: The Example of Flu in a Swiss Hospital
Ranjbar S., Cantoni E., Chavez-Demoulin V., Marra G., Radice R., Jaton K., 2022/08/01. Journal of the Royal Statistical Society Series C: Applied Statistics, 71 (4) pp. 884-905.
 
SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
Jacot D., von Rotz U., Blondet F., Aebischer O., Matthieu P., De Rham M., Pantaleo G., Marchetti O., Greub G., 2022/08. Journal of medical microbiology, 71 (8). Peer-reviewed.
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
Papadimitriou-Olivgeris M., Battistolo J., Poissy J., Coste A., Bochud P.Y., Calandra T., Senn L., Lamoth F., 2022/08. Open forum infectious diseases, 9 (8) pp. ofac383. Peer-reviewed.
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
The Impact of Epitranscriptomics on Antiviral Innate Immunity.
Mersinoglu B., Cristinelli S., Ciuffi A., 2022/07/28. Viruses, 14 (8) p. 1666. Peer-reviewed.
Covid long chez des individus infectés malgré le vaccin et effet du vaccin sur les symptômes.
Meylan P., 2022/07/06. Revue medicale suisse, 18 (789) pp. 1378-1379. Peer-reviewed.
 
Corrigendum to "A probabilistic approach to evaluate salivary microbiome in forensic science when the defense says: 'It is my twin brother'" [Forensic Sci. Int. Genet. 57, 102638].
Bozza S., Scherz V., Greub G., Falquet L., Taroni F., 2022/07..
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study.
Filippidis P., Kampouri E., Woelfle M., Badinski T., Croxatto A., Galperine T., Papadimitriou-Olivgeris M., Grandbastien B., Achermann Y., Guery B., 2022/06/30. Journal of clinical medicine, 11 (13) p. 3805. Peer-reviewed.
 
The EnvZ/OmpR Two-Component System Regulates the Antimicrobial Activity of TAT-RasGAP<sub>317-326</sub> and the Collateral Sensitivity to Other Antibacterial Agents.
Georgieva M., Heinonen T., Hargraves S., Pillonel T., Widmann C., Jacquier N., 2022/06/29. Microbiology spectrum, 10 (3) pp. e0200921. Peer-reviewed.
Utility of Polymerase Chain Reaction in Nasopharyngeal Swabs for Identifying Respiratory Bacteria Causing Community-Acquired Pneumonia.
Demars Y., Brahier T., Rotzinger D.C., Brouillet R., Jaton K., Opota O., Boillat-Blanco N., 2022/06/29. Microbiology spectrum, 10 (3) pp. e0037922. Peer-reviewed.
 
Performance Evaluation of the Quantamatrix QMAC-dRAST System for Rapid Antibiotic Susceptibility Testing Directly from Blood Cultures.
Rosselin M., Prod'hom G., Greub G., Croxatto A., 2022/06/14. Microorganisms, 10 (6) p. 1212. Peer-reviewed.
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Born T., Aruanno M., Kampouri E., Mombelli M., Monney P., Tozzi P., Lamoth F., 2022/06. Mycopathologia, 187 (2-3) pp. 249-258. Peer-reviewed.
 
Call for consensus in Chlamydia trachomatis nomenclature: moving from biovars, serovars, and serotypes to genovariants and genotypes.
de Vries HJC, Pannekoek Y., Dean D., Bavoil P.M., Borel N., Greub G., Morré S.A., ICSP Subcommittee on the Taxonomy of Chlamydiae, 2022/06. Clinical microbiology and infection, 28 (6) pp. 761-763. Peer-reviewed.
 
Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E. et al., 2022/06. Journal of general internal medicine, 37 (8) pp. 1943-1952. Peer-reviewed.
 
The unresolved issues in the management of mucormycosis.
Lamoth F., 2022/06. European journal of internal medicine, 100 pp. 29-30. Peer-reviewed.
 
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Manry J., Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M. et al., 2022/05/24. Proceedings of the National Academy of Sciences of the United States of America, 119 (21) pp. e2200413119. Peer-reviewed.
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Girardin F.R., Tzankov A., Pantaleo G., Livio F., Greub G., 2022/05/23. Swiss medical weekly, 152 pp. w30188. Peer-reviewed.
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
Assessment of SARS-CoV-2 tests costs and reimbursement tariffs readjustments during the COVID-19 pandemic.
Caruana G., Brouillet R., Opota O., Greub G., 2022/05/09. Swiss medical weekly, 152 pp. w30168. Peer-reviewed.
Evaluation of a Multiplex Real-Time PCR Assay for Detecting Chlamydia trachomatis in Vaginal Samples.
Kebbi-Beghdadi C., Aeby S., Baud D., Greub G., 2022/05/04. Diagnostics, 12 (5) p. 1141. Peer-reviewed.
Building up a clinical microbiota profiling: a quality framework proposal.
Scherz V., Greub G., Bertelli C., 2022/05. Critical reviews in microbiology, 48 (3) pp. 356-375. Peer-reviewed.
Enabling genomic island prediction and comparison in multiple genomes to investigate bacterial evolution and outbreaks.
Bertelli C., Gray K.L., Woods N., Lim A.C., Tilley K.E., Winsor G.L., Hoad G.R., Roudgar A., Spencer A., Peltier J. et al., 2022/05. Microbial genomics, 8 (5) pp. :000818. Peer-reviewed.
 
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.
Meyer Sauteur P.M., Beeton M.L., Uldum S.A., Bossuyt N., Vermeulen M., Loens K., Pereyre S., Bébéar C., Keše D., Day J. et al., 2022/05. Euro surveillance, 27 (19) pp. 32-50. Peer-reviewed.
 
Overview about Candida auris: What's up 12 years after its first description?
Desoubeaux G., Coste A.T., Imbert C., Hennequin C., 2022/05. Journal de mycologie medicale, 32 (2) p. 101248. Peer-reviewed.
 
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2022/04/19. Antimicrobial agents and chemotherapy, 66 (4) pp. e0006722. Peer-reviewed.
 
Impact of Acquired Broad-Spectrum β-Lactamases on Susceptibility to Cefiderocol and Newly Developed β-Lactam/β-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosa.
Poirel L., Ortiz de la Rosa J.M., Sadek M., Nordmann P., 2022/04/19. Antimicrobial agents and chemotherapy, 66 (4) pp. e0003922. Peer-reviewed.
Staphylococcus aureus résistant à la méticilline : 15 ans de surveillance moléculaire en Suisse romande [Methicillin-resistant Staphylococcus aureus: 15 years of molecular epidemiology in Western Switzerland]
Blanc D.S., Grandbastien B., Bally F., Lienhard R., Tritten M.L., Clerc O., Fracheboud D., Pfister S., Chuard C., Burr M. et al., 2022/04/13. Revue medicale suisse, 18 (777) pp. 724-728. Peer-reviewed.
Tularémie pulmonaire : un diagnostic à ne pas manquer [Pulmonary tularemia : a diagnosis not to be missed]
Uriel Valladares P., Opota O., Beigelman-Aubry C., Bochud P.Y., Lamoth F., 2022/04/13. Revue medicale suisse, 18 (777) pp. 707-711. Peer-reviewed.
Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization.
Bellefroid M., Rodari A., Galais M., Krijger PHL, Tjalsma SJD, Nestola L., Plant E., Vos ESM, Cristinelli S., Van Driessche B. et al., 2022/04/08. Nucleic acids research, 50 (6) pp. 3190-3202. Peer-reviewed.
Effets du confinement sur la mortalité du Covid-19 : revue de la littérature et méta-analyse.
Meylan P., 2022/04/06. Revue medicale suisse, 18 (776) pp. 686-687. Peer-reviewed.
A zebrafish reporter line reveals immune and neuronal expression of endogenous retrovirus.
Rutherford H.A., Clarke A., Chambers E.V., Petts J.J., Carson E.G., Isles H.M., Duque-Jaramillo A., Renshaw S.A., Levraud J.P., Hamilton N., 2022/04/01. Disease models & mechanisms, 15 (4) pp. dmm048921. Peer-reviewed.
 
Candida albicans commensalism in the oral mucosa is favoured by limited virulence and metabolic adaptation.
Lemberg C., Martinez de San Vicente K., Fróis-Martins R., Altmeier S., Tran VDT, Mertens S., Amorim-Vaz S., Rai L.S., d'Enfert C., Pagni M. et al., 2022/04. PLoS pathogens, 18 (4) pp. e1010012. Peer-reviewed.
 
Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants.
Poirel L., Sadek M., Kusaksizoglu A., Nordmann P., 2022/04. European journal of clinical microbiology & infectious diseases, 41 (4) pp. 677-680. Peer-reviewed.
 
Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli.
Nordmann P., Sadek M., Poirel L., Chakraborty T., 2022/04. European journal of clinical microbiology & infectious diseases, 41 (4) pp. 689-690. Peer-reviewed.
 
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians.
Lamoth F., 2022/04/01. Current opinion in infectious diseases, 35 (2) pp. 163-169. Peer-reviewed.
 
Comment on: Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
Nordmann P., Poirel L., 2022/03/31. The Journal of antimicrobial chemotherapy, 77 (4) p. 1209. Peer-reviewed.
 
Aliidiomarina shirensis as Possible Source of the Integron- and Plasmid-Mediated Fosfomycin Resistance Gene fosC2.
Ortiz de la Rosa J.M., Nordmann P., Zong Z., Poirel L., 2022/03/15. Antimicrobial agents and chemotherapy, 66 (3) pp. e0222721. Peer-reviewed.
Increasing Trends of Association of 16S rRNA Methylases and Carbapenemases in Enterobacterales Clinical Isolates from Switzerland, 2017-2020.
Fournier C., Poirel L., Despont S., Kessler J., Nordmann P., 2022/03/14. Microorganisms, 10 (3) p. 615. Peer-reviewed.
Nirmatrelvir oral pour les adultes non hospitalisés à haut risque atteints de Covid-19.
Meylan P., 2022/03/02. Revue medicale suisse, 18 (771) pp. 402-403. Peer-reviewed.
A probabilistic approach to evaluate salivary microbiome in forensic science when the Defense says: `It is my twin brother'.
Bozza S., Scherz V., Greub G., Falquet L., Taroni F., 2022/03. Forensic science international. Genetics, 57 p. 102638. Peer-reviewed.
Direct detection of extended-spectrum-β-lactamase-producers in Enterobacterales from blood cultures: a comparative analysis.
Boattini M., Bianco G., Comini S., Iannaccone M., Casale R., Cavallo R., Nordmann P., Costa C., 2022/03. European journal of clinical microbiology & infectious diseases, 41 (3) pp. 407-413. Peer-reviewed.
 
Lausannevirus bilevel set-points.
Mueller L., Moreno H., Kunz S., Greub G., 2022/03. New microbes and new infections, 46 p. 100966. Peer-reviewed.
Unexpected associations between respiratory viruses and bacteria with Pulmonary Function Testing in children suffering from Cystic Fibrosis (MUCOVIB study).
Scherz V., Caruana G., Taffé P., Brouillet R., Bertelli C., Jaton K., Fougère Y., Posfay-Barbe K.M., Mornand A., Rochat-Guignard I. et al., 2022/03. Journal of cystic fibrosis, 21 (2) pp. e158-e164. Peer-reviewed.
Acute abdominal emergency due to infectious enteritis: an observational study comparing Campylobacter spp. to other enteric pathogens in children.
Papathanasiou Terzi M.A., Prod'hom G., Croxatto A., Andrey V., Crisinel P.A., 2022/02/28. Swiss medical weekly, 152 pp. w30113. Peer-reviewed.
A refractory tenosynovitis of the wrist: a case report.
Boudon A., Opota O., Dan D., 2022/02/21. Journal of medical case reports, 16 (1) p. 75. Peer-reviewed.
 
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).
Scherrer A.U., Traytel A., Braun D.L., Calmy A., Battegay M., Cavassini M., Furrer H., Schmid P., Bernasconi E., Stoeckle M. et al., 2022/02/18. International journal of epidemiology, 51 (1) pp. 33-34j. Peer-reviewed.
Durée de protection contre les maladies bénignes et graves par les vaccins Covid-19.
Meylan P., 2022/02/16. Revue medicale suisse, 18 (769) pp. 298-299. Peer-reviewed.
 
A highly virulent variant of HIV-1 circulating in the Netherlands.
Wymant C., Bezemer D., Blanquart F., Ferretti L., Gall A., Hall M., Golubchik T., Bakker M., Ong S.H., Zhao L. et al., 2022/02/04. Science, 375 (6580) pp. 540-545. Peer-reviewed.
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.
Ragozzino S., Goldenberger D., Wright P.R., Zimmerli S., Mühlethaler K., Neofytos D., Riat A., Boggian K., Nolte O., Conen A. et al., 2022/02. Open forum infectious diseases, 9 (2) pp. ofab638. Peer-reviewed.
 
International Committee on Systematics of Prokaryotes Subcommittee on the taxonomy of Chlamydiae, minutes of the closed meeting, 07 October 2021, via Webex.
Borel N., Greub G., 2022/02. International journal of systematic and evolutionary microbiology, 72 (2) p. 005213. Peer-reviewed.
Neutralisation croisée des variants après une infection SARS-CoV-2 malgré le vaccin.
Meylan P., 2022/01/26. Revue medicale suisse, 18 (766) pp. 134-135. Peer-reviewed.
 
Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification.
Rodriguez-Temporal D., Alcaide F., Mareković I., O'Connor J.A., Gorton R., van Ingen J., Van den Bossche A., Héry-Arnaud G., Beauruelle C., Orth-Höller D. et al., 2022/01/24. Scientific reports, 12 (1) p. 1237. Peer-reviewed.
 
External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories.
Wegner F., Roloff T., Huber M., Cordey S., Ramette A., Gerth Y., Bertelli C., Stange M., Seth-Smith HMB, Mari A. et al., 2022/01/19. Journal of clinical microbiology, 60 (1) pp. e0169821. Peer-reviewed.
Remdésivir précoce pour prévenir l’évolution vers un Covid-19 sévère en ambulatoire.
Meylan P., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 90-91. Peer-reviewed.
 
Selective Culture Medium for Screening of Fosfomycin Resistance in Enterobacterales.
Nordmann P., Sadek M., Ortiz de la Rosa J.M., Pfister S., Fournier C., Poirel L., 2022/01/19. Journal of clinical microbiology, 60 (1) pp. e0206321. Peer-reviewed.
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
Bick A.G., Popadin K., Thorball C.W., Uddin M.M., Zanni M.V., Yu B., Cavassini M., Rauch A., Tarr P., Schmid P. et al., 2022/01/12. Scientific reports, 12 (1) p. 577. Peer-reviewed.
 
Case report: Disseminated Scedosporium apiospermum infection with invasive right atrial mass in a heart transplant patient.
Bourlond B., Cipriano A., Regamey J., Papadimitriou-Olivgeris M., Kamani C., Seidel D., Lamoth F., Muller O., Yerly P., 2022. Frontiers in cardiovascular medicine, 9 p. 1045353. Peer-reviewed.
Detection of SARS-CoV-2 infection clusters: The useful combination of spatiotemporal clustering and genomic analyses.
Choi Y., Ladoy A., De Ridder D., Jacot D., Vuilleumier S., Bertelli C., Guessous I., Pillonel T., Joost S., Greub G., 2022. Frontiers in public health, 10 p. 1016169. Peer-reviewed.
Editorial: Antifungal Resistance: From Molecular to Global Issues.
Hagiwara D., Fillinger S., Sanglard D., 2022. Frontiers in cellular and infection microbiology, 12 p. 867398. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University